# Study of Aranesp to Treat Anemia in Prostate Cancer Patients.

> **NCT00245895** · PHASE2 · COMPLETED · sponsor: **University of Washington** · enrollment: 20 (actual)

## Conditions studied

- Prostate Cancer
- Anemia

## Interventions

- **DRUG:** Aranesp

## Key facts

- **NCT ID:** NCT00245895
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-04
- **Primary completion:** —
- **Final completion:** 2005-02
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2007-11-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00245895

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00245895, "Study of Aranesp to Treat Anemia in Prostate Cancer Patients.". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00245895. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*